Atlas Trials

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis

Clinical trial NCT04930978 · UNKNOWN

Trial details

NCT number
NCT04930978
Sponsor
Tuberculosis Research Centre, India
Status
UNKNOWN
Study type
OBSERVATIONAL
COVID-19 Respiratory InfectionPulmonary Tuberculoses
Start date
2021-06-21
Primary completion
2024-06-20
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.